Evidence-Based Medicine Chasm: Can CMS, Industry Find Common Ground?
This article was originally published in The Gray Sheet
Executive Summary
CMS' growing emphasis on evidence-based medicine to inform reimbursement decisions increasingly will lead manufacturers to conduct "high-quality" clinical trials, according to Chief Medical Officer Sean Tunis
You may also be interested in...
Medicare Technical Corrections Legislation Doubtful After Rx Bill Passage
The resolve of House Republican leaders to avoid re-opening the controversial Medicare law with a technical corrections bill in 2004 will limit DME competitive bidding opponents' options in repealing the provision
Expanded ICD Patient Pool Augured By New Sub-Studies, Design Features
Cardiac rhythm management companies expect their investments in large randomized, controlled trials to spur increased adoption of ICDs this year
Expanded ICD Patient Pool Augured By New Sub-Studies, Design Features
Cardiac rhythm management companies expect their investments in large randomized, controlled trials to spur increased adoption of ICDs this year